Works matching AU Ezekowitz, Michael

Results: 66
    1
    2

    Central Clinical Research Issues in Electrophysiology: Report of the NASPE Committee.

    Published in:
    Pacing & Clinical Electrophysiology, 2001, v. 24, n. 4, p. 526, doi. 10.1046/j.1460-9592.2001.00526.x
    By:
    • Domanski, Michael J.;
    • Zipes, Douglas P.;
    • Benditt, David G.;
    • Camm, A. John;
    • Exner, Derek V.;
    • Ezekowitz, Michael D.;
    • Greene, H. Leon;
    • Lesh, Michael D.;
    • Miller, John M.;
    • Pratt, Craig M.;
    • Saksena, Sanjeev;
    • Scheinman, Melvin M.;
    • Singh, Bramah N.;
    • Tracy, Cynthia M.;
    • Waldot, Albert L.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    A randomized trial of budiodarone in paroxysmal atrial fibrillation.

    Published in:
    Journal of Interventional Cardiac Electrophysiology, 2012, v. 34, n. 1, p. 1, doi. 10.1007/s10840-011-9636-3
    By:
    • Ezekowitz, Michael;
    • Nagarakanti, Rangadham;
    • Lubinski, Andrzej;
    • Bandman, Olga;
    • Canafax, Daniel;
    • Ellis, David;
    • Milner, Peter;
    • Ziola, Margaret;
    • Thibault, Bernard;
    • Hohnloser, Stefan
    Publication type:
    Article
    9

    2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

    Published in:
    Journal of Interventional Cardiac Electrophysiology, 2012, v. 33, n. 2, p. 171, doi. 10.1007/s10840-012-9672-7
    By:
    • Calkins, Hugh;
    • Kuck, Karl;
    • Cappato, Riccardo;
    • Brugada, Josep;
    • Camm, A.;
    • Chen, Shih-Ann;
    • Crijns, Harry;
    • Damiano, Ralph;
    • Davies, D.;
    • DiMarco, John;
    • Edgerton, James;
    • Ellenbogen, Kenneth;
    • Ezekowitz, Michael;
    • Haines, David;
    • Haissaguerre, Michel;
    • Hindricks, Gerhard;
    • Iesaka, Yoshito;
    • Jackman, Warren;
    • Jalife, Jose;
    • Jais, Pierre
    Publication type:
    Article
    10
    11
    12
    13
    14

    Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

    Published in:
    JAMA Network Open, 2020, v. 3, n. 9, p. e2015943, doi. 10.1001/jamanetworkopen.2020.15943
    By:
    • Hijazi, Ziad;
    • Oldgren, Jonas;
    • Lindbäck, Johan;
    • Alexander, John H.;
    • Alings, Marco;
    • De Caterina, Raffaele;
    • Eikelboom, John W.;
    • Ezekowitz, Michael D.;
    • Held, Claes;
    • Huber, Kurt;
    • Hylek, Elaine M.;
    • Granger, Christopher B.;
    • Lopes, Renato D.;
    • Vinereanu, Dragos;
    • Siegbahn, Agneta;
    • Wallentin, Lars
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries.

    Published in:
    Clinical Cardiology, 2023, v. 46, n. 11, p. 1398, doi. 10.1002/clc.24109
    By:
    • Lim, Toon Wei;
    • Camm, Alan John;
    • Virdone, Saverio;
    • Singer, Daniel E.;
    • Bassand, Jean P.;
    • Fonarow, Gregg C.;
    • Fox, Keith A. A.;
    • Ezekowitz, Michael;
    • Gersh, Bernard J.;
    • Kayani, Gloria;
    • Hylek, Elaine M.;
    • Kakkar, Ajay K.;
    • Mahaffey, Kenneth W.;
    • Pieper, Karen S.;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.
    Publication type:
    Article
    21
    22
    23
    24

    Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.

    Published in:
    European Heart Journal, 2020, v. 41, n. 30, p. 2848, doi. 10.1093/eurheartj/ehaa247
    By:
    • Böhm, Michael;
    • Brueckmann, Martina;
    • Eikelboom, John W;
    • Ezekowitz, Michael;
    • Fräßdorf, Mandy;
    • Hijazi, Ziad;
    • Hohnloser, Stefan H;
    • Mahfoud, Felix;
    • Schmieder, Roland E;
    • Schumacher, Helmut;
    • Wallentin, Lars;
    • Yusuf, Salim
    Publication type:
    Article
    25
    26
    27
    28
    29

    Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

    Published in:
    2020
    By:
    • Kloosterman, Mariëlle;
    • Oldgren, Jonas;
    • Conen, David;
    • Wong, Jorge A;
    • Connolly, Stuart J;
    • Avezum, Alvaro;
    • Yusuf, Salim;
    • Ezekowitz, Michael D;
    • Wallentin, Lars;
    • Ntep-Gweth, Marie;
    • Joseph, Philip;
    • Barrett, Tyler W;
    • Tanosmsup, Supachai;
    • McIntyre, William F;
    • Lee, Shun Fu;
    • Parkash, Ratika;
    • Amit, Guy;
    • Grinvalds, Alex;
    • Gelder, Isabelle C Van;
    • Healey, Jeff S
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36
    37

    2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design.

    Published in:
    EP: Europace, 2012, v. 14, n. 4, p. 528
    By:
    • Calkins, Hugh;
    • Kuck, Karl Heinz;
    • Cappato, Riccardo;
    • Brugada, Josep;
    • Camm, A. John;
    • Chen, Shih-Ann;
    • Crijns, Harry J.G.;
    • Damiano, Ralph J.;
    • Davies, D. Wyn;
    • DiMarco, John;
    • Edgerton, James;
    • Ellenbogen, Kenneth;
    • Ezekowitz, Michael D.;
    • Haines, David E.;
    • Haissaguerre, Michel;
    • Hindricks, Gerhard;
    • Iesaka, Yoshito;
    • Jackman, Warren;
    • Jalife, Jose;
    • Jais, Pierre
    Publication type:
    Article
    38

    Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

    Published in:
    EP: Europace, 2012, v. 14, n. 1, p. 8, doi. 10.1093/europace/eur241
    By:
    • Kirchhof, Paulus;
    • Lip, Gregory Y.H.;
    • Van Gelder, Isabelle C.;
    • Bax, Jeroen;
    • Hylek, Elaine;
    • Kaab, Stefan;
    • Schotten, Ulrich;
    • Wegscheider, Karl;
    • Boriani, Giuseppe;
    • Brandes, Axel;
    • Ezekowitz, Michael;
    • Diener, Hans;
    • Haegeli, Laurent;
    • Heidbuchel, Hein;
    • Lane, Deirdre;
    • Mont, Luis;
    • Willems, Stephan;
    • Dorian, Paul;
    • Aunes-Jansson, Maria;
    • Blomstrom-Lundqvist, Carina
    Publication type:
    Article
    39

    Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.

    Published in:
    Journal of the American Heart Association, 2024, v. 13, n. 17, p. 1, doi. 10.1161/JAHA.123.034758
    By:
    • Johnson, Linda S.;
    • Benz, Alexander P.;
    • Shoamanesh, Ashkan;
    • Eikelboom, John W.;
    • Ezekowitz, Michael;
    • Giugliano, Robert P.;
    • Wallentin, Lars;
    • Ruff, Christian T.;
    • Lopes, Renato D.;
    • Jolly, Sanjit;
    • Whitlock, Richard;
    • Granger, Christopher B.;
    • Connolly, Stuart;
    • Healey, Jeffrey S.
    Publication type:
    Article
    40

    Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS<sub>2</sub> Score: A Subgroup Analysis of the RE-LY Trial.

    Published in:
    Annals of Internal Medicine, 2011, v. 155, n. 10, p. 660, doi. 10.7326/0003-4819-155-10-201111150-00004
    By:
    • Oldgren, Jonas;
    • Alings, Marco;
    • Darius, Harald;
    • Diener, Hans-Christoph;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Kamensky, Gabriel;
    • Reilly, Paul A.;
    • Sean Yang;
    • Yusuf, Salim;
    • Wallentin, Lars;
    • Connolly, Stuart J.
    Publication type:
    Article
    41

    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

    Published in:
    European Heart Journal, 2017, v. 38, n. 12, p. 860, doi. 10.1093/eurheartj/ehw069
    By:
    • Diener, Hans-Christoph;
    • Aisenberg, James;
    • Ansell, Jack;
    • Atar, Dan;
    • Breithardt, Günter;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Granger, Christopher B.;
    • Halperin, Jonathan L.;
    • Hohnloser, Stefan H.;
    • Hylek, Elaine M.;
    • Kirchhof, Paulus;
    • Lane, Deirdre A.;
    • Verheugt, FreekW.A.;
    • Veltkamp, Roland;
    • Lip, Gregory Y. H.
    Publication type:
    Article
    42

    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

    Published in:
    European Heart Journal, 2017, v. 38, n. 12, p. 852, doi. 10.1093/eurheartj/ehv643
    By:
    • Diener, Hans-Christoph;
    • Aisenberg, James;
    • Ansell, Jack;
    • Atar, Dan;
    • Breithardt, Günter;
    • Eikelboom, John;
    • Ezekowitz, Michael D.;
    • Granger, Christopher B.;
    • Halperin, Jonathan L.;
    • Hohnloser, Stefan H.;
    • Hylek, Elaine M.;
    • Kirchhof, Paulus;
    • Lane, Deirdre A.;
    • Verheugt, FreekW.A.;
    • Veltkamp, Roland;
    • Lip, Gregory Y. H.
    Publication type:
    Article
    43

    Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.

    Published in:
    European Heart Journal, 2014, v. 35, n. 47, p. 3346, doi. 10.1093/eurheartj/ehu367
    By:
    • Cappato, Riccardo;
    • Ezekowitz, Michael D.;
    • Klein, Allan L.;
    • Camm, A. John;
    • Ma, Chang-Sheng;
    • Le Heuzey, Jean-Yves;
    • Talajic, Mario;
    • Scanavacca, Maurício;
    • Vardas, Panos E.;
    • Kirchhof, Paulus;
    • Hemmrich, Melanie;
    • Lanius, Vivian;
    • Meng, Isabelle Ling;
    • Wildgoose, Peter;
    • van Eickels, Martin;
    • Hohnloser, Stefan H.
    Publication type:
    Article
    44
    45

    LVS-HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World-Wide Registry.

    Published in:
    2021
    By:
    • Johnson, Linda S. B.;
    • Oldgren, Jonas;
    • Barrett, Tyler W.;
    • McNaughton, Candace D.;
    • Wong, Jorge A.;
    • McIntyre, William F.;
    • Freeman, Clifford L.;
    • Murphy, Laura;
    • Engström, Gunnar;
    • Ezekowitz, Michael;
    • Connolly, Stuart J.;
    • Lizhen Xu;
    • Nakamya, Juliet;
    • Conen, David;
    • Bangdiwala, Shrikant I.;
    • Yusuf, Salim;
    • Healey, Jeff S.;
    • Xu, Lizhen
    Publication type:
    journal article
    46
    47
    48

    Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

    Published in:
    2018
    By:
    • Steinberg, Benjamin A.;
    • Shrader, Peter;
    • Pieper, Karen;
    • Thomas, Laine;
    • Allen, Larry A.;
    • Ansell, Jack;
    • Chan, Paul S.;
    • Ezekowitz, Michael D.;
    • Fonarow, Gregg C.;
    • Freeman, James V.;
    • Gersh, Bernard J.;
    • Kowey, Peter R.;
    • Mahaffey, Kenneth W.;
    • Naccarelli, Gerald V.;
    • Reiffel, James A.;
    • Singer, Daniel E.;
    • Peterson, Eric D.;
    • Piccini, Jonathan P.;
    • the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators;
    • Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators
    Publication type:
    journal article
    49
    50